monoclonal LC was isolated and purified from urine samples and then subjected to liquid chromatography tandem mass spectrometry (LC-MS/MS) to map the sequences; laser microdissection combining mass spectrometry (LMD/MS) was applied to determine the pathogenic LC in renal deposits.